
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            A Comparative Nonrandomised Observational Study of Different Modalities of Renal Replacement Therapy (Continuous Renal Replacement Therapy vs. Sustained Low Efficiency Dialysis) With Acute Kidney Injury in an Intensive Care Unit Setup: A Pilot Study - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A2288AF1E33305A228001481043B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cureus">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374745/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cureus">
<meta name="citation_title" content="A Comparative Nonrandomised Observational Study of Different Modalities of Renal Replacement Therapy (Continuous Renal Replacement Therapy vs. Sustained Low Efficiency Dialysis) With Acute Kidney Injury in an Intensive Care Unit Setup: A Pilot Study">
<meta name="citation_author" content="Choudhury Sudhiranjan Dash">
<meta name="citation_author_institution" content="Nephrology, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, IND">
<meta name="citation_author" content="Rishit Harbada">
<meta name="citation_author_institution" content="Nephrology, Jaslok Hospital and Research Center, Mumbai, IND">
<meta name="citation_author" content="Rushi V Deshpande">
<meta name="citation_author_institution" content="Nephrology, Jaslok Hospital and Research Center, Mumbai, IND">
<meta name="citation_author" content="Amjad Khan Pathan">
<meta name="citation_author_institution" content="Nephrology, Jaslok Hospital and Research Center, Mumbai, IND">
<meta name="citation_publication_date" content="2025 Jul 24">
<meta name="citation_volume" content="17">
<meta name="citation_issue" content="7">
<meta name="citation_firstpage" content="e88678">
<meta name="citation_doi" content="10.7759/cureus.88678">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374745/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374745/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374745/pdf/cureus-0017-00000088678.pdf">
<meta name="description" content="Background: This study investigated the comparable efficacy of sustained low-efficiency dialysis (SLED) over continuous renal replacement therapy (CRRT) in maintaining hemodynamic stability in critically ill patients with acute kidney injury (AKI) ...">
<meta name="og:title" content="A Comparative Nonrandomised Observational Study of Different Modalities of Renal Replacement Therapy (Continuous Renal Replacement Therapy vs. Sustained Low Efficiency Dialysis) With Acute Kidney Injury in an Intensive Care Unit Setup: A Pilot Study">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Background: This study investigated the comparable efficacy of sustained low-efficiency dialysis (SLED) over continuous renal replacement therapy (CRRT) in maintaining hemodynamic stability in critically ill patients with acute kidney injury (AKI) ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374745/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374745">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.7759/cureus.88678"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/cureus-0017-00000088678.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374745%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374745/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374745/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374745/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cureus.png" alt="Cureus logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cureus" title="Link to Cureus" shape="default" href="http://www.cureus.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cureus</button></div>. 2025 Jul 24;17(7):e88678. doi: <a href="https://doi.org/10.7759/cureus.88678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.7759/cureus.88678</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cureus%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cureus%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cureus%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cureus%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>A Comparative Nonrandomised Observational Study of Different Modalities of Renal Replacement Therapy (Continuous Renal Replacement Therapy vs. Sustained Low Efficiency Dialysis) With Acute Kidney Injury in an Intensive Care Unit Setup: A Pilot Study</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dash%20CS%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Choudhury Sudhiranjan Dash</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Choudhury Sudhiranjan Dash</span></h3>
<div class="p">
<sup>1</sup>
Nephrology, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, IND </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dash%20CS%22%5BAuthor%5D" class="usa-link"><span class="name western">Choudhury Sudhiranjan Dash</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Harbada%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Rishit Harbada</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Rishit Harbada</span></h3>
<div class="p">
<sup>2</sup>
Nephrology, Jaslok Hospital and Research Center, Mumbai, IND </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Harbada%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rishit Harbada</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deshpande%20RV%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Rushi V Deshpande</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Rushi V Deshpande</span></h3>
<div class="p">
<sup>2</sup>
Nephrology, Jaslok Hospital and Research Center, Mumbai, IND </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deshpande%20RV%22%5BAuthor%5D" class="usa-link"><span class="name western">Rushi V Deshpande</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20Pathan%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Amjad Khan Pathan</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Amjad Khan Pathan</span></h3>
<div class="p">
<sup>2</sup>
Nephrology, Jaslok Hospital and Research Center, Mumbai, IND </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20Pathan%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Amjad Khan Pathan</span></a>
</div>
</div>
<sup>2</sup>
</div>
<div class="cg p">Editors: <span class="name western">Alexander Muacevic</span>, <span class="name western">John R Adler</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff-1">
<sup>1</sup>
Nephrology, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, IND </div>
<div id="aff-2">
<sup>2</sup>
Nephrology, Jaslok Hospital and Research Center, Mumbai, IND </div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">
Choudhury Sudhiranjan Dash <span>sudhiranjan72@gmail.com</span>
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Accepted 2025 Jul 24; Collection date 2025 Jul.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025, Dash et al.</div>
<p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374745</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Background: This study investigated the comparable efficacy of sustained low-efficiency dialysis (SLED) over continuous renal replacement therapy (CRRT) in maintaining hemodynamic stability in critically ill patients with acute kidney injury (AKI) in an intensive care unit (ICU).</p>
<p>Methods: A single-centre, prospective observational study was conducted at Jaslok Hospital and Research Centre, Mumbai, involving 67 patients requiring RRT in the ICU. Thirty-five patients were included in the CRRT (Baxter Prismaflex System, USA) cohort, and 32 patients were included in the SLED (Fresenius 4008S, Fresenius Medical Care, Bad Hamburg, Germany) cohort. A total of 58 sessions of CRRT and 87 sessions of SLED were analysed.</p>
<p>Results: The median duration of CRRT was 1.93 days, whereas the median duration of SLED was 0.73 days. The mean duration of dialysis and mean ultrafiltration rate per session were 46.48+/-37.65 hours and 17.61+/-13.2 hours, and 23.77+/-26.72ml/hr and 103.51+/-108 ml/hr, respectively, in the CRRT and SLED cohorts. Metrics such as the Delta VI, Delta VD, Sequential Organ Failure Assessment (SOFA), and Acute Physiological Assessment and Chronic Health Evaluation (APACHE-2) Scores were evaluated within 48 hours of therapy initiation, along with 28-day mortality rates and complication assessments. The mortality rates at 48 hours and all-cause mortality rates at 28 days were 45.71% and 50% and 77.14% and 78.12% between the CRRT and SLED cohorts, respectively. Between survivors and nonsurvivors, the SOFA and APACHE-2 scores showed statistical significance. A SOFA score of ≥11 and an APACHE II score of &gt;20 are associated with a negative short-term outcome. During the process of therapy, complications of clinical significance were filter clotting, hypokalemia, hypophosphatemia, and arrhythmias. Although we could not observe statistically significant differences between the groups, they could still contribute towards untoward outcomes if left untreated.</p>
<p>Conclusion: While both therapies showed similar baseline characteristics and outcomes, the SLED demonstrated a potential advantage in terms of reduced filter clotting incidents and logistics, making it an attractive alternative in resource-limited settings. The results highlight the equivalent efficacy of the SLED in delivering RRT while supporting hemodynamic stability in critically ill patients.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> acute kidney injury, continuous renal replacement therapy (crrt), sustained low-efficiency dialysis (sled), vasopressor dependency, vasopressor index</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Acute kidney injury (AKI) is one of the earliest clinical conditions to be described in the medical literature. William Herbenden first mentioned acute renal failure (ARF) in the early 20th century, as early as 1902, and coined the term ischuria renalis. Since then, the nomenclature for ARF has been redefined 35 times in different studies [<a href="#REF1" class="usa-link" aria-describedby="REF1">1</a>]. To resolve this confusion, the term ARF was replaced by AKI.</p>
<p>AKI is defined as a rapid decline in the glomerular filtration rate occurring over minutes to days, with retention of nitrogenous waste products, namely, blood urea nitrogen, creatinine, and others [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>]. Depending on the deﬁnition used, the incidence of AKI ranges from 1% to 25% in intensive care unit (ICU) patients, with mortality rates ranging between 15% and 60% [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>-<a href="#REF4" class="usa-link" aria-describedby="REF4">4</a>]. AKI-associated mortality has changed little over the years despite advances in medical care, mostly due to the increasing age and the complexity of patients suffering from AKI. AKI is one of the most common and serious complications in critically ill patients admitted to the ICU and is considered an independent risk factor for morbidity and mortality. The term AKI encompasses the entire spectrum of the syndrome from minor changes in markers of renal function to the requirement for renal replacement therapy (RRT) [<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>].</p>
<p>To restore the systemic milieu in critically ill patients, different modalities of RRT are offered when indicated. These include intermittent hemodialysis (IHD), prolonged intermittent renal replacement therapy (PIRRT), sustained low efficiency dialysis (SLED), and continuous renal replacement therapy (CRRT). In critically ill patients with hemodynamic instability, the latter three are more appropriate. There is a debate in the literature regarding the superiority of convective clearance of solute via CRRT vs. diffusive clearance via SLED. Convective clearance is considered less efﬁcient than diffusive clearance, but its continuous nature compensates for its drawback; moreover, bulk solute removal with CRRT is reportedly greater than that with IHD. Other advantages of CRRT over IHD include better hemodynamic stability and achievement of the ultrafiltration goal in a controlled environment. In addition, there is a better control of acid/base and electrolyte status, uremic toxins, and inflammatory mediator removal, particularly in patients with systemic inﬂammatory response syndrome (SIRS). SLED is a hybrid modality that has components taken from both CRRT and IHD, with an efficacy equivalent to that of CRRT and fewer disadvantages (cost, resources, and mobility restrictions for any procedure). These advantages of SLED have been widely reported in medical literature; however, they are not universally accepted. Despite the advancements in the understanding and management of AKI, including the introduction of RRT, mortality in ICU patients with AKI remains largely unimproved and unacceptably high [<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>]. Mortality in ICU patients with AKI severe enough to require RRT has been reported to be as high as 80% [<a href="#REF7" class="usa-link" aria-describedby="REF7">7</a>,<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>].</p>
<p>Therefore, this study aimed to compare the two modalities of RRT, i.e., SLED vs CRRT, with the assumption that SLED is not inferior to CRRT in terms of hemodynamic stability, complications, and dependence on RRT in critically ill patients with AKI. The study evaluated the hemodynamic stability of critically ill patients with AKI requiring RRT using two objective assessment tools, delta vasopressor index (DVI) and delta vasopressor dependency (DVD). Furthermore, we studied the early clinical deterioration in critically ill patients with AKI on RRT, defined as a rise in the Sequential Organ Failure Assessment (SOFA) score or death within 48 hours after starting RRT and mortality at 28 days after RRT initiation. The secondary objectives of the study included assessing the complications associated with the two RRT modalities and the persistent RRT dependence at 28 days.</p></section><section id="sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<p>Study design</p>
<p>This single-centre prospective observational study was carried out at Jaslok Hospital and Research Centre, Mumbai. The study was designed in accordance with the reporting guidelines endorsed by the Consolidated Standards of Reporting Trials (CONSORT) and the Strengthening of Observational Studies in Epidemiology (STROBE) statement [<a href="#REF9" class="usa-link" aria-describedby="REF9">9</a>]. The institutional review board approved the study after obtaining ethics committee approval (41st Ethics Committee Meeting/dated 05.08.2017), and it was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all patients or their next of kin or legal heir (for patients incapable of giving consent).</p>
<p>Study population</p>
<p>Patients with AKI requiring RRT admitted to the ICU between September 2017 and February 2019, who received SLED or CRRT, were included in the study. The inclusion criteria were age ≥18 years with AKI requiring RRT. Critically ill patients with chronic kidney disease (CKD) requiring RRT and patients with AKI who did not require RRT and were managed conservatively were excluded from the study</p>
<p>Sample size (n) calculation</p>
<p>The sample size for this study was calculated using the following formula described by Wan et al. [<a href="#REF10" class="usa-link" aria-describedby="REF10">10</a>]:</p>
<p> <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><img class="inline" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37bc/12374745/c8882b3efbde/M17559645144224339.gif" loading="lazy" id="M17559645144224339" alt="Inline graphic"></span>,</p>
<p>where S = standard deviation; q1 = first quartile; q3 = third quartile; Φ −1 is the inverse cumulative distribution function for normal distributions; n = sample size.</p>
<p>Using the above formula, the final sample size was computed as n = 60, with a minimum of 30 participants in each arm. Assuming a 10% dropout rate, the final sample size was inflated to n = 66.</p>
<p>Methodology</p>
<p>In this study, 67 patients, 35 inthe CRRT cohort and 32 in the SLED cohort, who fulfilled the inclusion criteria, were studied over a period of 18 months.</p>
<p>A complete thorough clinical examination and blood investigations were performed by the primary treating team, intensivists, and treating nephrologists. Preliminary clinical data, including patient demographics, comorbidities, severity scores (SOFA and APACHE II), AKI stage according to the KDIGO, and the aetiology of AKI, were collected. Laboratory parameters, including serum creatinine levels, arterial blood gas analysis (ABG) levels, electrolytes, lactate levels, procalcitonin levels, routine urine analysis, as well as hemodynamics, including blood pressure and fluid balance, were also collected.</p>
<p>Sepsis was defined as per the 2018 Surviving Sepsis Guidelines [<a href="#REF11" class="usa-link" aria-describedby="REF11">11</a>]. The source of sepsis was defined as the infection focus studied and was chiefly categorised as respiratory, intra-abdominal, which also included genito-urinary infections, haematological, or other infections. The decision to initiate RRT, the timing of RRT initiation, and the modality of RRT were made by the treating nephrologist. All measurements and data were collected by the same investigator.</p>
<p>A Fresenius 4008S hemodialysis machine (Fresenius Medical Care, Bad Hamburg, Germany) and a 1.4 m2 dialyser membrane (Polyflux Gambro, USA) were used for the patients undergoing SLED, while a CRRT machine (Baxter Prisma Flex System, USA) with an M-100 Prismaflex dialyser and the extra-corporeal circuit was used for patients undergoing CRRT. Dialysis duration, the total number of dialysis sessions, blood flow (Qb), dialysate flow (Qd), prescription, anticoagulation during dialysis, and ultrafiltration rates were determined by the treating nephrologist. Vasopressors were used to target a mean arterial pressure (MAP) of &gt;65 mmHg after adequate fluid resuscitation.</p>
<p>Hemodynamic metrics were described via two objective parameters, vasopressor index (VI) and vasopressor dependency (VD). Hemodynamic stability was calculated using the formula given by Mishra et al. [<a href="#REF12" class="usa-link" aria-describedby="REF12">12</a>]. The dose of vasoactive/vasopressor agent is expressed as the inotropic score (vasopressor index), a dimensionless variable calculated as: [(dopamine dose x 1)+(dobutamine dose x 1)+(adrenaline dose x 100)+(noradrenaline dose x100)+(phenylephrine dose x 100)+(vasopressin dose x 10)], where all doses are expressed as µg/kg/min, except vasopressin, which is expressed in units/h.</p>
<p>The modification to include vasopressin was considered as it is the second most common inotrope used in the ICU after norepinephrine. This score has also been referred to as the vasopressor score or catecholamine index [<a href="#REF13" class="usa-link" aria-describedby="REF13">13</a>-<a href="#REF16" class="usa-link" aria-describedby="REF16">16</a>]. This dose-response relationship is expressed as the vasopressor dependency index, which is calculated as the ratio of the inotropic score to MAP; the higher the score, the greater the vasopressor requirement. This step is performed to negate the effect of the MAP.</p>
<p>Vasopressor Index (VI) - [(dopamine dose x 1) + (Dobutamine dose x 1) + (adrenaline dose x 100) + (noradrenaline dose x100) + (phenylephrine dosex100) + (Vasopressin dose x 10)]</p>
<p>Vasopressor Dependency (VD) = VI/MAP x 100</p>
<p>The delta VI (∆VI) and delta VD (∆VD) were calculated as the difference between the predialysis value and the worst recorded value during the dialysis session. The comparison was performed by analysing the worst ∆VI and ∆VD value for each patient. In addition, other outcome parameters, such as mortality within 48 hours, change in SOFA score within 48 hours of RRT initiation, and complications during dialysis sessions, were recorded.</p>
<p>Objectives of the study</p>
<p>Primary Objectives</p>
<p>The primary objectives of this study are 1) to examine early clinical deterioration in critically ill patients with AKI on RRT, defined as a rise in SOFA score or death within 48 hours after starting RRT and to study mortality at 28 days after RRT initiation, and 2) to compare the different modalities of RRT utilised in critically ill patients with AKI and to determine whether prolonged intermittent renal replacement therapy (PIRRT)/slow low-efficiency extended dialysis (SLEED) is noninferior to continuous renal replacement therapy(CRRT).</p>
<p>Secondary Objective</p>
<p>The secondary objectives of this study are 1) to examine complications of RRT in both groups of patients and 2) to study persistent RRT dependence at 28 days.</p>
<p>Statistical analysis</p>
<p>Statistical analysis was performed using GNU PSPP version 0.10.1. Qualitative data are presented as frequency and percentage. The quantitative data are presented as mean ± SD. Categorical variables were compared using the chi-square or Fisher’s exact tests. A t-test was used to compare parametric variables. For nonparametric variables, the Mann-Whitney U Test was used to compare two groups. The odds ratio was calculated using the IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., Armonk, NY) software. A two-sided probability (P) value &lt;0.05 was considered statistically significant. The results were graphically represented where deemed necessary. As the study was a non-randomised observational study to reduce sampling bias, a logistic regression analysis was carried out for the variables.</p></section><section id="sec3"><h2 class="pmc_sec_title">Results</h2>
<p>A total of 67 patients (35 in the CRRT cohort and 32 in the SLED cohort) were included in the study.</p>
<p>In our study, the baseline characteristics of the two comparison groups, i.e. the CRRT and SLED, were similar (Table <a href="#TAB1" class="usa-link">1</a>). The SOFA and APACHE 2 scores did not statistically differ between the two groups. In addition, baseline laboratory and pre-dialysis variables were similar in both groups. The proportion of females in the CRRT group (23%) was less than that in the SLED group (47%), which showed a statistically significant value.</p>
<section class="tw xbox font-sm" id="TAB1"><h3 class="obj_head">Table 1.  Baseline characteristics of patients in the CRRT and SLED groups.</h3>
<div class="caption p"><p>SOFA: Sequential Organ Failure Assesment, APACHE II: Acute Physiology and Chronic Health Evaluation, COPD: chronic obstructive pulmonary disease, HRS: hepatorenal syndrome, TLC: total leucocyte count, APTT: activated partial thromboplastin time, INR: International Normalised Ratio, CRRT: continuous renal replacement therapy, SLED: sustained low-efficiency dialysis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Variable</td>
<td rowspan="1" colspan="1">CRRT(N = 35)</td>
<td rowspan="1" colspan="1">SLED (N = 32)</td>
<td rowspan="1" colspan="1">Test value</td>
<td rowspan="1" colspan="1">P-value</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Mean age (years)</td>
<td rowspan="1" colspan="1">56.17 ± 14.13</td>
<td rowspan="1" colspan="1">59.72 ± 14.08</td>
<td rowspan="1" colspan="1">1.03</td>
<td rowspan="1" colspan="1">0.31</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Gender distribution</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td rowspan="1" colspan="1">Males: females</td>
<td rowspan="1" colspan="1">27:8</td>
<td rowspan="1" colspan="1">17:15</td>
<td rowspan="1" colspan="1">4.28</td>
<td rowspan="1" colspan="1">0.0701</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Severity scoring</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td rowspan="1" colspan="1">SOFA score</td>
<td rowspan="1" colspan="1">11 ± 2.44</td>
<td rowspan="1" colspan="1">11.16 ± 2.61</td>
<td rowspan="1" colspan="1">0.30</td>
<td rowspan="1" colspan="1">0.766</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">APACHE II score</td>
<td rowspan="1" colspan="1">21.65 ± 8.24</td>
<td rowspan="1" colspan="1">24.81 ± 8.66</td>
<td rowspan="1" colspan="1">1.53</td>
<td rowspan="1" colspan="1">0.131</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Comorbidities</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Diabetes mellitus</td>
<td rowspan="1" colspan="1">16 (50%)</td>
<td rowspan="1" colspan="1">14 (43.75%)</td>
<td rowspan="1" colspan="1">0.26</td>
<td rowspan="1" colspan="1">0.872</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Hypertension</td>
<td rowspan="1" colspan="1">16 (50%)</td>
<td rowspan="1" colspan="1">18 (56.25%)</td>
<td rowspan="1" colspan="1">0.123</td>
<td rowspan="1" colspan="1">0.726</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">COPD</td>
<td rowspan="1" colspan="1">1 (2.94%)</td>
<td rowspan="1" colspan="1">3 (9.37%)</td>
<td rowspan="1" colspan="1">1.265</td>
<td rowspan="1" colspan="1">0.261</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Ischemic heart disease</td>
<td rowspan="1" colspan="1">7 (20%)</td>
<td rowspan="1" colspan="1">7 (21.87%)</td>
<td rowspan="1" colspan="1">0.26</td>
<td rowspan="1" colspan="1">0.85</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Aetiology of AKI</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sepsis</td>
<td rowspan="1" colspan="1">20 (57.1%)</td>
<td rowspan="1" colspan="1">22 (68.75%)</td>
<td rowspan="1" colspan="1">0.963</td>
<td rowspan="1" colspan="1">0.326</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Cardiogenic shock</td>
<td rowspan="1" colspan="1">7 (20%)</td>
<td rowspan="1" colspan="1">4 (12.5%)</td>
<td rowspan="1" colspan="1">0.685</td>
<td rowspan="1" colspan="1">0.408</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Liver AKI (HRS)</td>
<td rowspan="1" colspan="1">7 (20%)</td>
<td rowspan="1" colspan="1">4 (12.5%)</td>
<td rowspan="1" colspan="1">0.685</td>
<td rowspan="1" colspan="1">0.247</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Tumour lysis syndrome</td>
<td rowspan="1" colspan="1">1 (2.9%)</td>
<td rowspan="1" colspan="1">2 (6.25%)</td>
<td rowspan="1" colspan="1">0.450</td>
<td rowspan="1" colspan="1">0.502</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Laboratory parameters</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Hemoglobin g/dL</td>
<td rowspan="1" colspan="1">9.69 ± 1.38</td>
<td rowspan="1" colspan="1">9.3 ± 1.54</td>
<td rowspan="1" colspan="1">1.208</td>
<td rowspan="1" colspan="1">0.23</td>
</tr>
<tr>
<td rowspan="1" colspan="1">TLC cu/ml</td>
<td rowspan="1" colspan="1">17089 ± 8395.3</td>
<td rowspan="1" colspan="1">16751 ± 8621</td>
<td rowspan="1" colspan="1">0.163</td>
<td rowspan="1" colspan="1">.871</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Platelets x10<sup>9 </sup>/L</td>
<td rowspan="1" colspan="1">143.25 ± 56.85</td>
<td rowspan="1" colspan="1">176.75±80.74</td>
<td rowspan="1" colspan="1">1.981</td>
<td rowspan="1" colspan="1">.052</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Aptt (seconds)</td>
<td rowspan="1" colspan="1">35.13 ± 4.96</td>
<td rowspan="1" colspan="1">33.72±3.83</td>
<td rowspan="1" colspan="1">1.293</td>
<td rowspan="1" colspan="1">0.201</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">INR </td>
<td rowspan="1" colspan="1">1.72 ± 0.57</td>
<td rowspan="1" colspan="1">1.6 ± 0.45</td>
<td rowspan="1" colspan="1">0.948</td>
<td rowspan="1" colspan="1">0.35</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Procalcitonin (ng/ml)</td>
<td rowspan="1" colspan="1">28.3 ± 45.8</td>
<td rowspan="1" colspan="1">30.4 ± 33.2</td>
<td rowspan="1" colspan="1">0.213</td>
<td rowspan="1" colspan="1">0.83</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Lactate (mmol/L)</td>
<td rowspan="1" colspan="1">8.94 ± 4.06</td>
<td rowspan="1" colspan="1">10.71 ± 4.67</td>
<td rowspan="1" colspan="1">1.66</td>
<td rowspan="1" colspan="1">0.102</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Pre-dialysis variables</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Creatinine (mg%)</td>
<td rowspan="1" colspan="1">3.31 ± 1.79</td>
<td rowspan="1" colspan="1">4.21 ±2.22</td>
<td rowspan="1" colspan="1">1.819</td>
<td rowspan="1" colspan="1">0.074</td>
</tr>
<tr>
<td rowspan="1" colspan="1">pH</td>
<td rowspan="1" colspan="1">7.26 ± 0.12</td>
<td rowspan="1" colspan="1">7.29 ± 0.085</td>
<td rowspan="1" colspan="1">0.952</td>
<td rowspan="1" colspan="1">0.344</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Bicarbonate (mEq/L)</td>
<td rowspan="1" colspan="1">13.95 ± 4.88</td>
<td rowspan="1" colspan="1">12.26 ± 5.14</td>
<td rowspan="1" colspan="1">1.373</td>
<td rowspan="1" colspan="1">0.175</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Potassium (mEq/L)</td>
<td rowspan="1" colspan="1">5.15 ± 1.03</td>
<td rowspan="1" colspan="1">5.29 ± 0.99</td>
<td rowspan="1" colspan="1">0.595</td>
<td rowspan="1" colspan="1">0.554</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Table <a href="#TAB2" class="usa-link">2</a> shows a comparison of the indications for RRT initiation between the two groups. There were no significant differences noted between the two groups.</p>
<section class="tw xbox font-sm" id="TAB2"><h3 class="obj_head">Table 2. Indication for RRT initiation.</h3>
<div class="caption p"><p>RRT: renal replacement therapy, CRRT: continuous renal replacement therapy, SLED: sustained low-efficiency dialysis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Indication for RRT</td>
<td rowspan="1" colspan="1">CRRT</td>
<td rowspan="1" colspan="1">SLED</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Anuria</td>
<td rowspan="1" colspan="1">16 (45.7%)</td>
<td rowspan="1" colspan="1">15 (46.88%)</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Metabolic acidosis</td>
<td rowspan="1" colspan="1">8 (22.86%)</td>
<td rowspan="1" colspan="1">6 (18.75%)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Uremia/azotemia</td>
<td rowspan="1" colspan="1">6 (17.14%)</td>
<td rowspan="1" colspan="1">6 (18.75%)</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Hyperkalemia</td>
<td rowspan="1" colspan="1">5 (14.29%)</td>
<td rowspan="1" colspan="1">5 (15.63%)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Total</td>
<td rowspan="1" colspan="1">35(100%)</td>
<td rowspan="1" colspan="1">32(100%)</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>A total of 58 sessions of CRRT were analysed. The median number of days per patient was 1.93 days. The mean duration of dialysis was 46.48 ± 37.65 hours. The mean blood flow (Qb) in these sessions was 110.29 ± 18.1 ml/min. The mean dialysate flow (Qd) was 1.064 ± 194.6 L/h. The mean ultrafiltrate removal per session was 23.77± 26.72 ml/h.</p>
<p>Eighty-seven sessions of SLED were analysed. The median number of days per patient was 0.73 days. The mean duration of dialysis was 17.61 ± 13.2 hours. The mean blood flow (Qb) in these sessions was 120.63 ± 19.33 ml/min. The mean dialysate flow (Qd) was 18.0 ± L/h. The mean ultrafiltrate removal rate per session was 103.51 ± 108 ml/h.</p>
<p>The predialysis VI was 38.35 ± 28.37 and 45.74 ± 26.39 in the CRRT and SLED cohorts, respectively. The intra-dialytic VI was 77.48 ± 45.07 and 81.5 ± 42.44 in the CRRT and SLED cohorts, respectively. The intradialytic hypotension, which was measured in terms of ΔVI, in the CRRT group (39.13 ± 24.17) was comparable to that in the SLED group (35.77 ± 26.78). The predialysis MAP was 73.22 ± 6.89 mmHg and 72.15±7.18 mmHg in the CRRT and SLED cohorts, respectively. The mean MAP recorded was 67.22 ± 6.92 mmHg in the CRRT group and 66.87 ± 5.717 mmHg in the SLED group. In our study, the hemodynamic variables remained comparable between the two cohorts (Table <a href="#TAB3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="TAB3"><h3 class="obj_head">Table 3. Mean of the hemodynamic variables in the study groups.</h3>
<div class="caption p">
<p>VI: vasopressure index, VD: vasopressure dependence, MAP: mean arterial pressure, Delta VI: Delta VI, Delta VD: Delta VD, CRRT: continuous renal replacement therapy, SLED: sustained low-efficiency dialysis</p>
<p>Delta VI and Delta VD were calculated as the difference between the predialysis value and the worst recorded value during the dialysis session.</p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Hemodynamic variables</td>
<td rowspan="1" colspan="1">CRRT  </td>
<td rowspan="1" colspan="1">SLED  </td>
<td rowspan="1" colspan="1">t-value</td>
<td rowspan="1" colspan="1">P-value</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Vasopressor index (VI) (predialysis)</td>
<td rowspan="1" colspan="1">38.35 ± 28.37</td>
<td rowspan="1" colspan="1">45.73 ± 26.39</td>
<td rowspan="1" colspan="1">1.10</td>
<td rowspan="1" colspan="1">0.276</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Vasopressor dependence (VD)  (predialysis)</td>
<td rowspan="1" colspan="1">54.76 ± 44.97</td>
<td rowspan="1" colspan="1">65.84 ± 41.29</td>
<td rowspan="1" colspan="1">1.047</td>
<td rowspan="1" colspan="1">0.299</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Mean arterial pressure (MAP) (predialysis)</td>
<td rowspan="1" colspan="1">73.22 ± 6.89</td>
<td rowspan="1" colspan="1">72.15 ± 7.18</td>
<td rowspan="1" colspan="1">0.623</td>
<td rowspan="1" colspan="1">0. 535</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">VI (intradialytic)</td>
<td rowspan="1" colspan="1">77.48 ± 45.07</td>
<td rowspan="1" colspan="1">81.5 ± 42.44</td>
<td rowspan="1" colspan="1">0.375</td>
<td rowspan="1" colspan="1">0.709</td>
</tr>
<tr>
<td rowspan="1" colspan="1">VD (intradialytic)</td>
<td rowspan="1" colspan="1">121 ± 81.65</td>
<td rowspan="1" colspan="1">125.79 ± 71.05</td>
<td rowspan="1" colspan="1">0.256</td>
<td rowspan="1" colspan="1">0.80</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">MAP (intradialytic)</td>
<td rowspan="1" colspan="1">67.22 ± 6.92</td>
<td rowspan="1" colspan="1">66.87 ± 5.717</td>
<td rowspan="1" colspan="1">0.227</td>
<td rowspan="1" colspan="1">0.821</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Delta VI</td>
<td rowspan="1" colspan="1">39.13 ± 24.17</td>
<td rowspan="1" colspan="1">35.77 ± 26.78</td>
<td rowspan="1" colspan="1">0.541</td>
<td rowspan="1" colspan="1">0.591</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Delta VD</td>
<td rowspan="1" colspan="1">66.24 ± 47.11</td>
<td rowspan="1" colspan="1">59.94 ± 47.28</td>
<td rowspan="1" colspan="1">0.545</td>
<td rowspan="1" colspan="1">0.587</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>The vasopressor dependency was 54.76 ± 44.97 in the CRRT cohort and 65.84 ± 41.29 in the SLED cohort. The VDs were 121 ± 81.65 and 125.79 ± 71.05 in the CRRT and SLED cohorts, respectively. There was no statistically significant difference in the intradialytic hypotension, which was measured in terms of ΔVD, between SLED (59.94 ± 47.28) and CRRT (66.24 ± 47.11) groups. Both modalities were equal in terms of hemodynamic tolerability, with no statistically significant difference. A regression analysis was carried out for ΔVI and ΔVD, respectively, between the SLED and CRRT groups (Tables <a href="#TAB4" class="usa-link">4</a>, <a href="#TAB5" class="usa-link">5</a>). There was no significant difference elicited between the two groups. ANOVA performed considering Delta VI and Delta VD as dependent variables did not show any statistical difference.</p>
<section class="tw xbox font-sm" id="TAB4"><h3 class="obj_head">Table 4. Regression analysis on the Delta vasopressor index (ΔVI) between CRRT and SLED.</h3>
<div class="caption p">
<p> a. Dependent variable: VIDiff</p>
<p>b. Predictors: (Constant), APACHEScore_PreDailysis, APTT (Activated Partial Thromboplastin Time), comorbid, CREATININE, PCT (Procalcitonine), OUTCOME, GROUP GROUP, K (Potassium), SEX, Agegr, PT_INR (International Normalise Ratio), HB (Hemoglobin), TLC (Total Leucocyte Count), LACTATE, PLATELET, SOFAscore_Predailysis, Bicarbonate, Ph</p>
<p>CRRT: continuous renal replacement therapy, SLED: sustained low-efficiency dialysis</p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Model</td>
<td rowspan="1" colspan="1">Unstandardised B</td>
<td rowspan="1" colspan="1">Coefficient standard error</td>
<td rowspan="1" colspan="1">Standardised coefficient beta</td>
<td rowspan="1" colspan="1">t</td>
<td rowspan="1" colspan="1">sig</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Constant</td>
<td rowspan="1" colspan="1">-203.566</td>
<td rowspan="1" colspan="1">447.225</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">-0.455</td>
<td rowspan="1" colspan="1">0.651</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Sex</td>
<td rowspan="1" colspan="1">-2.830</td>
<td rowspan="1" colspan="1">7.991</td>
<td rowspan="1" colspan="1">-0.053</td>
<td rowspan="1" colspan="1">-0.354</td>
<td rowspan="1" colspan="1">0.725</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Comorbid</td>
<td rowspan="1" colspan="1">-2.384</td>
<td rowspan="1" colspan="1">3.952</td>
<td rowspan="1" colspan="1">-0.098</td>
<td rowspan="1" colspan="1">-0.603</td>
<td rowspan="1" colspan="1">0.549</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Hb (gm%)</td>
<td rowspan="1" colspan="1">-2.252</td>
<td rowspan="1" colspan="1">2.637</td>
<td rowspan="1" colspan="1">-0.130</td>
<td rowspan="1" colspan="1">-0.854</td>
<td rowspan="1" colspan="1">0.397</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Total leucocyte count (TLC)cu/ml</td>
<td rowspan="1" colspan="1">0.000</td>
<td rowspan="1" colspan="1">0.001</td>
<td rowspan="1" colspan="1">0.148</td>
<td rowspan="1" colspan="1">0.825</td>
<td rowspan="1" colspan="1">0.414</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Platelet x10<sup>9 </sup>/L</td>
<td rowspan="1" colspan="1">-0.017</td>
<td rowspan="1" colspan="1">0.069</td>
<td rowspan="1" colspan="1">-0.048</td>
<td rowspan="1" colspan="1">-0.248</td>
<td rowspan="1" colspan="1">0.805</td>
</tr>
<tr>
<td rowspan="1" colspan="1">PT_INR (seconds)</td>
<td rowspan="1" colspan="1">-7.063</td>
<td rowspan="1" colspan="1">8.935</td>
<td rowspan="1" colspan="1">-0.144</td>
<td rowspan="1" colspan="1">-0.791</td>
<td rowspan="1" colspan="1">0.433</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">APTT (seconds)</td>
<td rowspan="1" colspan="1">0.075</td>
<td rowspan="1" colspan="1">0.864</td>
<td rowspan="1" colspan="1">0.013</td>
<td rowspan="1" colspan="1">0.087</td>
<td rowspan="1" colspan="1">0.931</td>
</tr>
<tr>
<td rowspan="1" colspan="1">PCT (ng/ml)</td>
<td rowspan="1" colspan="1">0.012</td>
<td rowspan="1" colspan="1">0.098</td>
<td rowspan="1" colspan="1">0.019</td>
<td rowspan="1" colspan="1">0.123</td>
<td rowspan="1" colspan="1">0.902</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Lactate (mmol/l)</td>
<td rowspan="1" colspan="1">0.695</td>
<td rowspan="1" colspan="1">1.075</td>
<td rowspan="1" colspan="1">0.121</td>
<td rowspan="1" colspan="1">0.646</td>
<td rowspan="1" colspan="1">0.521</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Creatinine (mg%)</td>
<td rowspan="1" colspan="1">-.3.525</td>
<td rowspan="1" colspan="1">1.862</td>
<td rowspan="1" colspan="1">-0.285</td>
<td rowspan="1" colspan="1">-1.893</td>
<td rowspan="1" colspan="1">0.064</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">pH</td>
<td rowspan="1" colspan="1">31.816</td>
<td rowspan="1" colspan="1">63.057</td>
<td rowspan="1" colspan="1">0.137</td>
<td rowspan="1" colspan="1">0.505</td>
<td rowspan="1" colspan="1">0.616</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Bicarbonate (meq/l)</td>
<td rowspan="1" colspan="1">1.133</td>
<td rowspan="1" colspan="1">1.287</td>
<td rowspan="1" colspan="1">0.226</td>
<td rowspan="1" colspan="1">0.880</td>
<td rowspan="1" colspan="1">0.383</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Potassium (meq/l)</td>
<td rowspan="1" colspan="1">1.843</td>
<td rowspan="1" colspan="1">3.867</td>
<td rowspan="1" colspan="1">0.074</td>
<td rowspan="1" colspan="1">0.477</td>
<td rowspan="1" colspan="1">0.636</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Group-Grp</td>
<td rowspan="1" colspan="1">-3.526</td>
<td rowspan="1" colspan="1">8.856</td>
<td rowspan="1" colspan="1">-0.070</td>
<td rowspan="1" colspan="1">-0.398</td>
<td rowspan="1" colspan="1">0.692</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Outcome</td>
<td rowspan="1" colspan="1">-8.850</td>
<td rowspan="1" colspan="1">9.218</td>
<td rowspan="1" colspan="1">-0.147</td>
<td rowspan="1" colspan="1">-0.960</td>
<td rowspan="1" colspan="1">0.342</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age group in years (Group 1 &lt;50, Group 2 51-60, Group 3 61-70, Group 4 &gt;71 )</td>
<td rowspan="1" colspan="1">0.047</td>
<td rowspan="1" colspan="1">3.995</td>
<td rowspan="1" colspan="1">0.002</td>
<td rowspan="1" colspan="1">0.012</td>
<td rowspan="1" colspan="1">0.991</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">SOFA score (predialysis)</td>
<td rowspan="1" colspan="1">2.182</td>
<td rowspan="1" colspan="1">2.189</td>
<td rowspan="1" colspan="1">0.216</td>
<td rowspan="1" colspan="1">0.997</td>
<td rowspan="1" colspan="1">0.324</td>
</tr>
<tr>
<td rowspan="1" colspan="1">APACHE 2 score (predialysis)</td>
<td rowspan="1" colspan="1">0.647</td>
<td rowspan="1" colspan="1">0.861</td>
<td rowspan="1" colspan="1">0.227</td>
<td rowspan="1" colspan="1">0.783</td>
<td rowspan="1" colspan="1">0.437</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="TAB5"><h3 class="obj_head">Table 5. Regression analysis on Delta vasopressor dependence (ΔVD) between CRRT and SLED.</h3>
<div class="caption p">
<p> a. Dependent variable: Delta VD </p>
<p>b. Predictors: (Constant), APACHEScore_PreDailysis APACHE Score_PreDailysis, APTT, comorbid, CREATININE, PCT, OUTCOME, GROUP GROUP, K, SEX, Agegr, PT_INR PT_INR, HB, TLC, LACTATE, PLATELET, SOFAscore_Predailysis SOFAscore_Predailysis, HCO3, PH</p>
<p> CRRT: continuous renal replacement therapy, SLED: sustained low-efficiency dialysis</p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Model</td>
<td rowspan="1" colspan="1">Unstandardised B</td>
<td rowspan="1" colspan="1">Coefficient standard error</td>
<td rowspan="1" colspan="1">Standardised coefficient beta</td>
<td rowspan="1" colspan="1">t</td>
<td rowspan="1" colspan="1">sig</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Constant</td>
<td rowspan="1" colspan="1">174.362</td>
<td rowspan="1" colspan="1">819.292</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">0.213</td>
<td rowspan="1" colspan="1">0.832</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Sex</td>
<td rowspan="1" colspan="1">-.7.310</td>
<td rowspan="1" colspan="1">14.639</td>
<td rowspan="1" colspan="1">-0.074</td>
<td rowspan="1" colspan="1">-0.499</td>
<td rowspan="1" colspan="1">0.620</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Comorbid</td>
<td rowspan="1" colspan="1">-.3.351</td>
<td rowspan="1" colspan="1">7.241</td>
<td rowspan="1" colspan="1">-0.075</td>
<td rowspan="1" colspan="1">-0.463</td>
<td rowspan="1" colspan="1">0.646</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Hb (gm%)</td>
<td rowspan="1" colspan="1">-4.183</td>
<td rowspan="1" colspan="1">4.832</td>
<td rowspan="1" colspan="1">-0.131</td>
<td rowspan="1" colspan="1">-0.866</td>
<td rowspan="1" colspan="1">0.391</td>
</tr>
<tr>
<td rowspan="1" colspan="1">TLC (cu/ml)</td>
<td rowspan="1" colspan="1">0.001</td>
<td rowspan="1" colspan="1">0.001</td>
<td rowspan="1" colspan="1">0.169</td>
<td rowspan="1" colspan="1">0.955</td>
<td rowspan="1" colspan="1">0.344</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Platelet x10<sup>9</sup>/L</td>
<td rowspan="1" colspan="1">-0.016</td>
<td rowspan="1" colspan="1">0.126</td>
<td rowspan="1" colspan="1">-0.024</td>
<td rowspan="1" colspan="1">-0.128</td>
<td rowspan="1" colspan="1">0.898</td>
</tr>
<tr>
<td rowspan="1" colspan="1">PT_INR</td>
<td rowspan="1" colspan="1">-12.703</td>
<td rowspan="1" colspan="1">16.369</td>
<td rowspan="1" colspan="1">-0.140</td>
<td rowspan="1" colspan="1">-0.776</td>
<td rowspan="1" colspan="1">0.442</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">APTT (seconds)</td>
<td rowspan="1" colspan="1">0.005</td>
<td rowspan="1" colspan="1">1.582</td>
<td rowspan="1" colspan="1">0.001</td>
<td rowspan="1" colspan="1">0.003</td>
<td rowspan="1" colspan="1">0.997</td>
</tr>
<tr>
<td rowspan="1" colspan="1">PCT (ng/ml)</td>
<td rowspan="1" colspan="1">0.050</td>
<td rowspan="1" colspan="1">0.179</td>
<td rowspan="1" colspan="1">0.042</td>
<td rowspan="1" colspan="1">0.278</td>
<td rowspan="1" colspan="1">0.783</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Lactate (mmol/l)</td>
<td rowspan="1" colspan="1">.718</td>
<td rowspan="1" colspan="1">1.969</td>
<td rowspan="1" colspan="1">0.068</td>
<td rowspan="1" colspan="1">0.365</td>
<td rowspan="1" colspan="1">0.717</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Creatinine (mg%)</td>
<td rowspan="1" colspan="1">-5.562</td>
<td rowspan="1" colspan="1">3.410</td>
<td rowspan="1" colspan="1">-0.242</td>
<td rowspan="1" colspan="1">-1.631</td>
<td rowspan="1" colspan="1">0.109</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">pH</td>
<td rowspan="1" colspan="1">-16.164</td>
<td rowspan="1" colspan="1">115.517</td>
<td rowspan="1" colspan="1">-0.038</td>
<td rowspan="1" colspan="1">-0.140</td>
<td rowspan="1" colspan="1">0.889</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Bicarbonate (meq/l)</td>
<td rowspan="1" colspan="1">2.026</td>
<td rowspan="1" colspan="1">2.358</td>
<td rowspan="1" colspan="1">0.218</td>
<td rowspan="1" colspan="1">0.860</td>
<td rowspan="1" colspan="1">0.394</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Potassium( meq/l)</td>
<td rowspan="1" colspan="1">1.957</td>
<td rowspan="1" colspan="1">7.084</td>
<td rowspan="1" colspan="1">0.042</td>
<td rowspan="1" colspan="1">0.276</td>
<td rowspan="1" colspan="1">0.783</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Group-Grp</td>
<td rowspan="1" colspan="1">-4.184</td>
<td rowspan="1" colspan="1">16.224</td>
<td rowspan="1" colspan="1">-0.045</td>
<td rowspan="1" colspan="1">-0.258</td>
<td rowspan="1" colspan="1">0.798</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Outcome</td>
<td rowspan="1" colspan="1">-17.781</td>
<td rowspan="1" colspan="1">16.888</td>
<td rowspan="1" colspan="1">-0.159</td>
<td rowspan="1" colspan="1">-1.053</td>
<td rowspan="1" colspan="1">0.298</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age group in years (group 1 &lt;50, Group 2 51-60, Group 3 61-70, Group 4 &gt;71)</td>
<td rowspan="1" colspan="1">1.181</td>
<td rowspan="1" colspan="1">7.319</td>
<td rowspan="1" colspan="1">0.027</td>
<td rowspan="1" colspan="1">0.161</td>
<td rowspan="1" colspan="1">0.872</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">SOFA Score-Predialysis</td>
<td rowspan="1" colspan="1">4.153</td>
<td rowspan="1" colspan="1">4.011</td>
<td rowspan="1" colspan="1">0.222</td>
<td rowspan="1" colspan="1">1.035</td>
<td rowspan="1" colspan="1">0.306</td>
</tr>
<tr>
<td rowspan="1" colspan="1">APACHE 2 Score_Predialysis</td>
<td rowspan="1" colspan="1">0.971</td>
<td rowspan="1" colspan="1">1.578</td>
<td rowspan="1" colspan="1">0.176</td>
<td rowspan="1" colspan="1">0.616</td>
<td rowspan="1" colspan="1">0.541</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>The signs of early clinical deterioration were mortality within 48 hours of RRT initiation and an increase in the SOFA and APACHE scores. Among the 67 patients who underwent RRT, all-cause mortality at 28 days was 77.14% in the CRRT cohort and 78.12% in the SLED cohort. The mortality rates at the end of 48 hours were 45.71% and 50% in the CRRT and SLED cohorts, respectively. The mortality rate within 48 hours of initiation in the CRRT cohort was lower than that in the SLED cohort. However, there was no statistically significant difference in mortality between the two groups (Table <a href="#TAB6" class="usa-link">6</a>). The relative risk of mortality within 48 hours was 1% higher in the SLED group, but not statistically significant (RR = 1.09 with 95% confidence interval 0.66-1.8, p = 0.72). The relative risk of mortality was equal in both groups, while for mortality at 28 days, the RR was 1.01 (95% CI, 0.78-1.3, p = 0.92).</p>
<section class="tw xbox font-sm" id="TAB6"><h3 class="obj_head">Table 6. Comparison of dependence on RRT among the study subjects.</h3>
<div class="caption p"><p>RRT: renal replacement therapy, CRRT: continuous renal replacement therapy, SLED: sustained low-efficiency dialysis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Variable</td>
<td rowspan="1" colspan="1">CRRT</td>
<td rowspan="1" colspan="1">SLED</td>
<td rowspan="1" colspan="1">P-value</td>
</tr>
<tr>
<td rowspan="1" colspan="1">  Dependence on RRT</td>
<td rowspan="1" colspan="1">2 (40%)</td>
<td rowspan="1" colspan="1">3 (42.85%)</td>
<td rowspan="1" colspan="1">  0.46</td>
</tr>
<tr style="background-color:#ccc"><td colspan="4" rowspan="1">Mortality within 48 hours and within 28 days of RRT initiation</td></tr>
<tr>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">CRRT</td>
<td rowspan="1" colspan="1">SLED</td>
<td rowspan="1" colspan="1">P-Value</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Mortality within 48 hours of initiation of RRT</td>
<td rowspan="1" colspan="1">16 (45.71%)</td>
<td rowspan="1" colspan="1">16 (50%)</td>
<td rowspan="1" colspan="1">0.73</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Mortality within 28 days of initiation of RRT</td>
<td rowspan="1" colspan="1">27 (77.14%)</td>
<td rowspan="1" colspan="1">25 (78.12%)</td>
<td rowspan="1" colspan="1">0.92</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>The mean APACHE score among the non-survivors in the CRRT group was 22.7 ± 7.7, whereas that of the survivors was 18.12 ± 9.24. The mean APACHE-2 scores of the non-survivors and survivors of the SLED group were 25.52 ± 9.34 and 8.71 ± 2.36, respectively. The survivors in both groups had lower APACHE scores, but the difference was not statistically significant (Table <a href="#TAB7" class="usa-link">7</a>).</p>
<section class="tw xbox font-sm" id="TAB7"><h3 class="obj_head">Table 7. Mean comparison of APACHE 2 score and SOFA score between survivors and non-survivors.</h3>
<div class="caption p"><p>SOFA: Sequential Organ Failure Assessment, APACHE-2: Acute Physiological Assessment and Chronic Health Evaluation, SLED: sustained low-efficiency dialysis, CRRT: continuous renal replacement therapy</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="2" colspan="1"> </td>
<td colspan="3" rowspan="1">CRRT  </td>
<td colspan="3" rowspan="1">SLED  </td>
<td rowspan="2" colspan="1">P-value</td>
</tr>
<tr>
<td colspan="2" rowspan="1">N</td>
<td rowspan="1" colspan="1">Mean ± SD of APACHE 2 score</td>
<td colspan="2" rowspan="1">N</td>
<td rowspan="1" colspan="1">Mean ± SD APACHE 2 score</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Non-survivors</td>
<td rowspan="1" colspan="1">27</td>
<td colspan="2" rowspan="1">22.7±7.7</td>
<td rowspan="1" colspan="1">25</td>
<td colspan="2" rowspan="1">25.52±9.34</td>
<td rowspan="1" colspan="1">0.12</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Survivors</td>
<td rowspan="1" colspan="1">8  </td>
<td colspan="2" rowspan="1">18.12±9.24</td>
<td rowspan="1" colspan="1">7</td>
<td colspan="2" rowspan="1">8.71±2.36</td>
<td rowspan="1" colspan="1">0.15</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">P-value</td>
<td rowspan="1" colspan="1"> </td>
<td colspan="2" rowspan="1">0.08  </td>
<td rowspan="1" colspan="1"> </td>
<td colspan="2" rowspan="1">0.19</td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr><td colspan="8" rowspan="1">Mean comparison of SOFA score among survivors and non-survivors</td></tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">N</td>
<td colspan="2" rowspan="1">Mean+/- SD of SOFA score</td>
<td rowspan="1" colspan="1">N</td>
<td colspan="2" rowspan="1">Mean +/- SD SOFA score</td>
<td rowspan="1" colspan="1">P-value</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Non-survivors</td>
<td rowspan="1" colspan="1">27</td>
<td colspan="2" rowspan="1">11.44+/-2.34</td>
<td rowspan="1" colspan="1">25</td>
<td colspan="2" rowspan="1">11.84+/-2.28</td>
<td rowspan="1" colspan="1">0.27</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Survivors</td>
<td rowspan="1" colspan="1">8</td>
<td colspan="2" rowspan="1">9.37+/-2.19</td>
<td rowspan="1" colspan="1">7</td>
<td colspan="2" rowspan="1">8.71+/-2.36</td>
<td rowspan="1" colspan="1">0.5</td>
</tr>
<tr>
<td rowspan="1" colspan="1">P-value</td>
<td rowspan="1" colspan="1"> </td>
<td colspan="2" rowspan="1">0.01</td>
<td rowspan="1" colspan="1"> </td>
<td colspan="2" rowspan="1">0.001</td>
<td rowspan="1" colspan="1"> </td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Among the 35 patients in the CRRT group, eight (22.8%) patients survived, and 27 (77.1%) patients died. The mean SOFA scores of the non-survivors and survivors in the CRRT group were 11.44 ± 2.34 and 9.37 ± 2.19, respectively. The SOFA score among the non-survivors was much greater than that among survivors, and the difference was statistically significant. Among the 32 patients in the SLED group, seven patients survived and 25 died. The mean SOFA scores of the non-survivors and survivors were 11.84 ± 2.28 and 8.71 ± 2.36, respectively. The SOFA score among the survivors was significantly lower than that among the non-survivors (Table <a href="#TAB7" class="usa-link">7</a>).</p>
<p>There were significant statistical differences noted between the survivors and non-survivors in both groups with respect to Delta VI and Delta VD (Table <a href="#TAB8" class="usa-link">8</a>). Also, there is statistical significance noted between survivors between the CRRT and SLED groups for Delta VI. This table signifies lower Delta VI and Delta VD scores at the initiation of RRT, whether CRRT or SLED, show a favourable prognosis. </p>
<section class="tw xbox font-sm" id="TAB8"><h3 class="obj_head">Table 8. Mean comparison of Delta VI and Delta VD between survivors and non-survivors.</h3>
<div class="caption p"><p>Delta VD: difference of vasopressure dependence, Delta VI: difference of vasopressure index, CRRT: continuous renal replacement therapy, SLED: sustained low-efficiency dialysis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">CRRT</td>
<td rowspan="1" colspan="1">Mean ± SD of Delta VI</td>
<td rowspan="1" colspan="1">SLED  </td>
<td rowspan="1" colspan="1">Mean ± SD of Delta VI</td>
<td rowspan="1" colspan="1">P-value</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Non-survivors</td>
<td rowspan="1" colspan="1">27</td>
<td rowspan="1" colspan="1">42.57 ± 26.1</td>
<td rowspan="1" colspan="1">25</td>
<td rowspan="1" colspan="1">41.34 ± 27.34</td>
<td rowspan="1" colspan="1">0.37</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Survivors</td>
<td rowspan="1" colspan="1">8  </td>
<td rowspan="1" colspan="1">27.52 ± 10.31</td>
<td rowspan="1" colspan="1">7</td>
<td rowspan="1" colspan="1">15.85 ± 11.14</td>
<td rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td rowspan="1" colspan="1">P-value</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">0.04</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">0.001  </td>
<td rowspan="1" colspan="1"> </td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">CRRT</td>
<td rowspan="1" colspan="1">Mean ± SD of Delta VD</td>
<td rowspan="1" colspan="1">SLED</td>
<td rowspan="1" colspan="1">Mean ± SD of Delta VD</td>
<td rowspan="1" colspan="1">P value</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Non-survivor</td>
<td rowspan="1" colspan="1">27</td>
<td rowspan="1" colspan="1">73.88 ± 50.60</td>
<td rowspan="1" colspan="1">25</td>
<td rowspan="1" colspan="1">69.72 ± 48.52</td>
<td rowspan="1" colspan="1">0.25</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Survivor</td>
<td rowspan="1" colspan="1">8</td>
<td rowspan="1" colspan="1">40.44 ± 16.74</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">25.04 ± 17.69</td>
<td rowspan="1" colspan="1">0.92</td>
</tr>
<tr>
<td rowspan="1" colspan="1">P-value</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">0.01</td>
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">0.004</td>
<td rowspan="1" colspan="1"> </td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>As the patients were not randomised, a logistic regression was carried out between the survivors and non-survivors in the CRRT and SLED groups for ΔVI and ΔVD to reduce the chance of selection bias. There was no statistically significant difference noted between the two groups except in the SOFA score and ultrafiltration (Table <a href="#TAB9" class="usa-link">9</a>).</p>
<section class="tw xbox font-sm" id="TAB9"><h3 class="obj_head">Table 9. Outcome: survivors with non-survivors (logistic regression).</h3>
<div class="caption p"><p>SE: standard error, SIG: p-value, Exp(B): odds ratio, PT/INR: prothrombin time/international normalised ratio, APTT: activated partial thromboplastin time, SOFA: Sequential Organ Failure Assessment, APACHE: Acute Physiological Assessment and Chronic Health Evaluation</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">B</td>
<td rowspan="1" colspan="1">SE</td>
<td rowspan="1" colspan="1">Sig</td>
<td rowspan="1" colspan="1">Exp(B) odds ratio</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age-group (years)</td>
<td rowspan="1" colspan="1">0.262</td>
<td rowspan="1" colspan="1">1.125</td>
<td rowspan="1" colspan="1">0.816</td>
<td rowspan="1" colspan="1">1.300</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Sex</td>
<td rowspan="1" colspan="1">-4.133</td>
<td rowspan="1" colspan="1">2.285</td>
<td rowspan="1" colspan="1">0.70</td>
<td rowspan="1" colspan="1">0.016</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Comorbidity</td>
<td rowspan="1" colspan="1">-2.710</td>
<td rowspan="1" colspan="1">1.406</td>
<td rowspan="1" colspan="1">0.054</td>
<td rowspan="1" colspan="1">0.067</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Platelet x10<sup>9</sup>/L</td>
<td rowspan="1" colspan="1">0.000</td>
<td rowspan="1" colspan="1">0.014</td>
<td rowspan="1" colspan="1">0.968</td>
<td rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td rowspan="1" colspan="1">PT/INR</td>
<td rowspan="1" colspan="1">-1.645</td>
<td rowspan="1" colspan="1">1.761</td>
<td rowspan="1" colspan="1">0.350</td>
<td rowspan="1" colspan="1">0.193</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">APTT (seconds)</td>
<td rowspan="1" colspan="1">-0.124</td>
<td rowspan="1" colspan="1">0.148</td>
<td rowspan="1" colspan="1">0.404</td>
<td rowspan="1" colspan="1">.884</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Procalcitonin (ng/ml)</td>
<td rowspan="1" colspan="1">0.003</td>
<td rowspan="1" colspan="1">0.017</td>
<td rowspan="1" colspan="1">0.873</td>
<td rowspan="1" colspan="1">1.003</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Lactate (mmol/l)</td>
<td rowspan="1" colspan="1">0.390</td>
<td rowspan="1" colspan="1">0.298</td>
<td rowspan="1" colspan="1">0.191</td>
<td rowspan="1" colspan="1">1.477</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Creatinine (mg%)</td>
<td rowspan="1" colspan="1">0.990</td>
<td rowspan="1" colspan="1">0.525</td>
<td rowspan="1" colspan="1">0.059</td>
<td rowspan="1" colspan="1">2.692</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">pH</td>
<td rowspan="1" colspan="1">-10.147</td>
<td rowspan="1" colspan="1">13.841</td>
<td rowspan="1" colspan="1">0.464</td>
<td rowspan="1" colspan="1">0.000</td>
</tr>
<tr>
<td rowspan="1" colspan="1">HCO3 (meq/l)</td>
<td rowspan="1" colspan="1">0.509</td>
<td rowspan="1" colspan="1">0.401</td>
<td rowspan="1" colspan="1">0.205</td>
<td rowspan="1" colspan="1">1.663</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Potassium (meq/l)</td>
<td rowspan="1" colspan="1">-1.284</td>
<td rowspan="1" colspan="1">0.819</td>
<td rowspan="1" colspan="1">0.117</td>
<td rowspan="1" colspan="1">0.277</td>
</tr>
<tr>
<td rowspan="1" colspan="1">SOFA Score-Predialysis</td>
<td rowspan="1" colspan="1">-2.214</td>
<td rowspan="1" colspan="1">0.786</td>
<td rowspan="1" colspan="1">0.005</td>
<td rowspan="1" colspan="1">.109</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">APACHE-2 Score-Predialysis</td>
<td rowspan="1" colspan="1">0.378</td>
<td rowspan="1" colspan="1">0.237</td>
<td rowspan="1" colspan="1">0.111</td>
<td rowspan="1" colspan="1">1.459</td>
</tr>
<tr>
<td rowspan="1" colspan="1">UF (litre)</td>
<td rowspan="1" colspan="1">0.001</td>
<td rowspan="1" colspan="1">0.001</td>
<td rowspan="1" colspan="1">0.031</td>
<td rowspan="1" colspan="1">1.001</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Group</td>
<td rowspan="1" colspan="1">-1.976</td>
<td rowspan="1" colspan="1">2.306</td>
<td rowspan="1" colspan="1">.392</td>
<td rowspan="1" colspan="1">.139</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Constant</td>
<td rowspan="1" colspan="1">94.237</td>
<td rowspan="1" colspan="1">100.639</td>
<td rowspan="1" colspan="1">.349</td>
<td rowspan="1" colspan="1">8.446E+40</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>However, between the CRRT and SLED groups, APACHE-2 score, bicarbonate, pH, procalcitonin, platelet, and comorbidity showed statistical significance (Table <a href="#TAB10" class="usa-link">10</a>).</p>
<section class="tw xbox font-sm" id="TAB10"><h3 class="obj_head">Table 10. - Logistic regression analysis comparing CRRT VS SLED.</h3>
<div class="caption p"><p>SE -Standard Error , Sig- p value , Exp(B) - Odds Ratio</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1"> </td>
<td rowspan="1" colspan="1">B</td>
<td rowspan="1" colspan="1">SE</td>
<td rowspan="1" colspan="1">Sig (p)</td>
<td rowspan="1" colspan="1">Exp(B) Odds Ratio</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age group(years)</td>
<td rowspan="1" colspan="1">0.321</td>
<td rowspan="1" colspan="1">0.519</td>
<td rowspan="1" colspan="1">0.536</td>
<td rowspan="1" colspan="1">1.379</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">sex</td>
<td rowspan="1" colspan="1">0.381</td>
<td rowspan="1" colspan="1">1.010</td>
<td rowspan="1" colspan="1">0.706</td>
<td rowspan="1" colspan="1">1.464</td>
</tr>
<tr>
<td rowspan="1" colspan="1">comorbidity</td>
<td rowspan="1" colspan="1">-1.176</td>
<td rowspan="1" colspan="1">0.591</td>
<td rowspan="1" colspan="1">0.047</td>
<td rowspan="1" colspan="1">0.308</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Platelet x10<sup>9</sup>/L</td>
<td rowspan="1" colspan="1">0.025</td>
<td rowspan="1" colspan="1">0.011</td>
<td rowspan="1" colspan="1">0.019</td>
<td rowspan="1" colspan="1">1.025</td>
</tr>
<tr>
<td rowspan="1" colspan="1">PT/INR</td>
<td rowspan="1" colspan="1">-0.540</td>
<td rowspan="1" colspan="1">1.106</td>
<td rowspan="1" colspan="1">0.626</td>
<td rowspan="1" colspan="1">0.583</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">APTT(seconds)</td>
<td rowspan="1" colspan="1">-0.075</td>
<td rowspan="1" colspan="1">0.117</td>
<td rowspan="1" colspan="1">0.525</td>
<td rowspan="1" colspan="1">0.928</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Procalcitonin(ng/ml)</td>
<td rowspan="1" colspan="1">-0.016</td>
<td rowspan="1" colspan="1">0.014</td>
<td rowspan="1" colspan="1">0.014</td>
<td rowspan="1" colspan="1">0.954</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Lactate(mmol/l)</td>
<td rowspan="1" colspan="1">0.367</td>
<td rowspan="1" colspan="1">0.150</td>
<td rowspan="1" colspan="1">0.757</td>
<td rowspan="1" colspan="1">1.443</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Creatinine(mg%)</td>
<td rowspan="1" colspan="1">0.073</td>
<td rowspan="1" colspan="1">0.237</td>
<td rowspan="1" colspan="1">0.002</td>
<td rowspan="1" colspan="1">1.076</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">HCO3(meq/l)</td>
<td rowspan="1" colspan="1">-0.435</td>
<td rowspan="1" colspan="1">0.211</td>
<td rowspan="1" colspan="1">0.039</td>
<td rowspan="1" colspan="1">0.647</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Potassium(meq/l)</td>
<td rowspan="1" colspan="1">0.394</td>
<td rowspan="1" colspan="1">0.461</td>
<td rowspan="1" colspan="1">0.392</td>
<td rowspan="1" colspan="1">1.483</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">SOFA Score-Prdialyis</td>
<td rowspan="1" colspan="1">-0.186</td>
<td rowspan="1" colspan="1">0.329</td>
<td rowspan="1" colspan="1">0.572</td>
<td rowspan="1" colspan="1">0.830</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Apache-2 Score-PreDialysis</td>
<td rowspan="1" colspan="1">0.235</td>
<td rowspan="1" colspan="1">0.110</td>
<td rowspan="1" colspan="1">0.034</td>
<td rowspan="1" colspan="1">1.264</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">UF</td>
<td rowspan="1" colspan="1">0.000</td>
<td rowspan="1" colspan="1">0.000</td>
<td rowspan="1" colspan="1">0.559</td>
<td rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Outcome</td>
<td rowspan="1" colspan="1">-1.456</td>
<td rowspan="1" colspan="1">1.540</td>
<td rowspan="1" colspan="1">0.344</td>
<td rowspan="1" colspan="1">0.233</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Constant</td>
<td rowspan="1" colspan="1">-246.690</td>
<td rowspan="1" colspan="1">78.965</td>
<td rowspan="1" colspan="1">0.002</td>
<td rowspan="1" colspan="1">0.000</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Filter clotting (18.75% vs. 46.87%, SLED vs. CRRT, respectively) was the most common complication in the two study groups, followed by hypokalemia (15.63% vs. 34.37%), hypophosphatemia, and arrhythmia. The complications appeared to be less common in the SLED group, but the difference was not statistically significant, except for filter clotting (Table <a href="#TAB11" class="usa-link">11</a>).</p>
<section class="tw xbox font-sm" id="TAB11"><h3 class="obj_head">Table 11. Comparison of complications between the study groups.</h3>
<div class="caption p"><p>SLED: sustained low-efficiency dialysis, CRRT: continuous renal replacement therapy</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Variables</td>
<td rowspan="1" colspan="1">SLED</td>
<td rowspan="1" colspan="1">CRRT</td>
<td rowspan="1" colspan="1">Chi-square</td>
<td rowspan="1" colspan="1">P-value</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Filter clotting</td>
<td rowspan="1" colspan="1">6 (18.75%)</td>
<td rowspan="1" colspan="1">15 (46.87%)</td>
<td rowspan="1" colspan="1">4.514</td>
<td rowspan="1" colspan="1">0.032</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Hypokalemia</td>
<td rowspan="1" colspan="1">5 (15.63%)</td>
<td rowspan="1" colspan="1">11 (34.37%)</td>
<td rowspan="1" colspan="1">2.297</td>
<td rowspan="1" colspan="1">0.219</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Hypophosphatemia</td>
<td rowspan="1" colspan="1">2 (6.25%)</td>
<td rowspan="1" colspan="1">4 (12.5%)</td>
<td rowspan="1" colspan="1">0.550</td>
<td rowspan="1" colspan="1">0.75</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Arrhythmias</td>
<td rowspan="1" colspan="1">3 (9.37%)</td>
<td rowspan="1" colspan="1">6 (18.75%)</td>
<td rowspan="1" colspan="1">0.867</td>
<td rowspan="1" colspan="1">0.35</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Among critically ill patients, AKI requiring RRT continues to be associated with very high mortality, ranging from 50% to 80%, despite considerable technological advancements in RRT [<a href="#REF4" class="usa-link" aria-describedby="REF4">4</a>,<a href="#REF17" class="usa-link" aria-describedby="REF17">17</a>,<a href="#REF18" class="usa-link" aria-describedby="REF18">18</a>]. Both CRRT and SLED are used interchangeably; however, they are frequently driven by factors such as physicians’ prerogative, cost, and utilisation of resources, which are primary drivers in developing nations [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>].</p>
<p>Currently, there are no guidelines or consensus regarding a preferred RRT modality in a hemodynamically contingent setting. Both these techniques have their own merits and demerits. In comparison to IHD, CRRT is associated with improved hemodynamic stability, greater chances of recovery, better survival, control of volume overload, and azotemia. However, all these studies have compared CRRT to extensive historical control [<a href="#REF3" class="usa-link" aria-describedby="REF3">3</a>]. The disadvantages of CRRT include the need for anticoagulation, proprietary premanufactured solutions, high cost, the need for interruption to allow for off-unit testing, and the need to frequently interrupt the therapy to allow for tests and procedures [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>].</p>
<p>SLED is a hybrid technique with features of both CRRT and IHD that is used increasingly in developing countries for the management of AKI with hemodynamic instability. Owing to its easy availability, low cost, and reasonable expertise required in performing this therapy, it is gaining popularity as a preferred modality in most ICUs [<a href="#REF13" class="usa-link" aria-describedby="REF13">13</a>]. Therefore, this study assessed the suitability of SLED as an alternative to CRRT for hemodynamically unstable critically ill ICU patients.</p>
<p>Our study (Table <a href="#TAB1" class="usa-link">1</a>) included mainly elderly patients with a median age of 56.17 ± 14.13 years and 59.72 ± 14.08 years in the CRRT and SLED groups, respectively. This was similar to the study by Kitchlu A et al., who reported that the mean age of patients was estimated to be 62 ± 15.3 years and 60.6 ± 17.3 years in the CRRT and SLED groups, respectively [<a href="#REF15" class="usa-link" aria-describedby="REF15">15</a>]. Liaño et al. and Stevens et al. observed similar baseline characteristics in their study [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>,<a href="#REF19" class="usa-link" aria-describedby="REF19">19</a>]. AKI is emerging as the leading risk factor in elderly individuals, mainly owing to ageing kidneys along with a cumulative increase in the incidence of comorbidities and medication use, resulting in altered renal hemodynamics. In our study, more males suffered from AKI requiring RRT than females, i.e., 77% and 23% in the CRRT group against 53% and 47% in the SLED group, respectively. Major comorbidities, such as diabetes, hypertension, coronary artery disease, and chronic obstructive pulmonary disease, showed similar frequency distributions in the two groups. Moreover, approximately 73.09% of our cohort had at least one comorbidity at presentation, and the remaining 26.91% had no comorbidity. When we indexed the degree of comorbidities in our study, almost 16.41% had three comorbidities and 20.89% had two. Ali et al. reported a similar pattern of frequency distribution in their study group, i.e., 80%, 24%, and 18% of their cohort had one, two, and three comorbidities, respectively [<a href="#REF20" class="usa-link" aria-describedby="REF20">20</a>].</p>
<p>At baseline, there were no discrepancies between the two groups of the study population (Table <a href="#TAB1" class="usa-link">1</a>) with respect to the aetiology of AKI, SOFA score, or laboratory parameters, except total platelet count, which exceeded the level of significance; this signifies similar patient characteristics in both groups, possibly reducing the selection bias. </p>
<p>We followed the standard criteria for initiating RRT, which included uraemia, severe metabolic acidosis refractory to medical management, oliguria, fluid overload, and hyperkalaemia (Table <a href="#TAB2" class="usa-link">2</a>). Our findings are in accordance with those by Ponce et al., who reported that the main reasons for the initiation of RRT were oliguria/fluid overload, uraemia, metabolic acidosis, and hyperkalaemia, in descending order [<a href="#REF21" class="usa-link" aria-describedby="REF21">21</a>]. Mishra SB et al. reported metabolic acidosis as the major driver for the initiation of RRT, followed by hyperkalaemia and fluid overload [<a href="#REF12" class="usa-link" aria-describedby="REF12">12</a>].</p>
<p>Hemodynamic tolerance is a major concern in critically ill patients with AKI. The traditional usage of MAP as a tool for establishing hemodynamic tolerability has been questioned by various authors. A landmark study by Asfar et al. led to the foundation for titration of vasopressors according to MAP, which was later incorporated into the Surviving Sepsis Guidelines [<a href="#REF22" class="usa-link" aria-describedby="REF22">22</a>]. In their study, the patients were grouped as those with a higher MAP of more than 85 mm of Hg and those with a lower MAP of 70 to 84 mm of Hg. Their study did not find any significant difference between the two groups in terms of hard outcomes such as 28-day and 90-day mortalities. Moreover, the study revealed a progressive increase in mortality with an increase in the duration of exposure to a lower MAP of &lt;65 mmHg [<a href="#REF22" class="usa-link" aria-describedby="REF22">22</a>].</p>
<p>The objective and comparable concept of the VI and VD for hemodynamic instability assessment was proposed by Mishra SB et al. [<a href="#REF12" class="usa-link" aria-describedby="REF12">12</a>-<a href="#REF13" class="usa-link" aria-describedby="REF13">13</a>]. The advantage of these two parameters nullifies the effect of the measurement of MAP alone in hemodynamically unstable patients with AKI. They proposed that patient-to-patient variability does exist and that patients with chronic hypertension and diffuse atherosclerosis require a higher MAP for better organ perfusion; hence, a higher MAP was targeted. Delta VI ΔVI and ΔVD are more effective parameters, as they include the dose of inotropic requirements, which is better for titrating the dose of inotropes. </p>
<p>Kielstein et al. and Baldwin et al. compared CRRT and SLED in critically ill patients for hemodynamic stability and concluded that both are comparable in the correction of acidosis at the end of RRT [<a href="#REF23" class="usa-link" aria-describedby="REF23">23</a>,<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. In our study, hemodynamics in terms of VI, VD, MAP, Delta VI, and Delta VD were similar in both groups and did not significantly differ (Table <a href="#TAB3" class="usa-link">3</a>). A metanalysis published by Rabindranath et al. revealed that compared to patients receiving SLED, those receiving CRRT were less likely to need escalation of their inotropic support, maintaining a significantly greater MAP [<a href="#REF25" class="usa-link" aria-describedby="REF25">25</a>]. However, our analysis revealed discordant observations, with similar inotropic support escalation in both groups. A comparison of the parameters by logistic regression analysis and ANOVA revealed no statistically significant difference (Tables <a href="#TAB4" class="usa-link">4</a>, <a href="#TAB5" class="usa-link">5</a>).</p>
<p>Early clinical deterioration, defined as death within 48 hours, was observed in 45.71% and 50% of patients in the CRRT and SLED cohorts, respectively, in our study (Table <a href="#TAB6" class="usa-link">6</a>). The results obtained in our study were congruent with those reported by Kitchlu et al., with 45.2% in the CRRT group and 39.2% in the SLED group [<a href="#REF15" class="usa-link" aria-describedby="REF15">15</a>]. The SOFA score deteriorated in non-survivors at 48 hours from 12.55 ± 2.42 in the CRRT cohort and 12.77 ± 2.22 in the SLED cohort to 13.72 ± 1.79 and 14 ± 2.22, respectively (Table <a href="#TAB7" class="usa-link">7</a>). The VI, VD, ∆VI, ∆VD, and SOFA scores were significantly higher in non-survivors than in survivors at the time of initiation of RRT. The most likely explanation for this finding is that patients with higher pre-initiation vasopressor requirements showed greater hemodynamic worsening during SLED. Since VD ≥25 showed a good sensitivity, albeit only with modest specificity, it may be used as a predictor of a hemodynamically intolerable SLED session. Similarly, Delta VD was lower in survivors (&lt;40) and &gt;40 in non-survivors in our cohort (Table <a href="#TAB8" class="usa-link">8</a>). However, owing to the small sample in this study, a relevant relationship could not be established.</p>
<p>Finally, in another trial by Schoenfelder et al., it was observed that initial CRRT was associated with increased rates of renal recovery. CRRT does not significantly differ from intermittent renal replacement therapy in terms of change in MAP, hypotensive episodes, hemodynamic instability, and length of stay [<a href="#REF26" class="usa-link" aria-describedby="REF26">26</a>]. </p>
<p>AKI poses a very heavy burden on morbidity and mortality. In our study, out of 67 patients who underwent RRT, the total mortality rate at 28 days was 77.14 % in the CRRT cohort and 78.12% in the SLED cohort. </p>
<p>Ponce et al. reported a mortality rate of 71.9% among patients undergoing CRRT, while an Indian study by George et al. reported a mortality rate of 84% in the continuous venovenous hemodiafiltration (CVVHDF) group compared to 72% in the peritoneal dialysis (PD) group [<a href="#REF21" class="usa-link" aria-describedby="REF21">21</a>,<a href="#REF27" class="usa-link" aria-describedby="REF27">27</a>]. Kitchlu et al. reported all-cause mortality rates of 54% and 61% in the SLED and CRRT groups, respectively, at 30 days [<a href="#REF15" class="usa-link" aria-describedby="REF15">15</a>]. Schwenger V et al., in their single-centre study, compared PIRRT to CVVH in 232 critically ill patients. There was no difference in 90-day all-cause mortality between the PIRRT group and the CVVH group. Patients treated with PIRRT required fewer days of mechanical ventilation, required fewer days in the ICU, and received fewer blood transfusions, resulting in an overall lower cost of therapy [<a href="#REF28" class="usa-link" aria-describedby="REF28">28</a>]. A subsequent meta-analysis of seven randomised, controlled trials and 10 observational studies comparing PIRRT with CRRT revealed no difference in mortality or recovery of kidney function associated with the modality of therapy [<a href="#REF29" class="usa-link" aria-describedby="REF29">29</a>].</p>
<p>Long-term RRT dependence did not differ between the two groups in seven randomised trials [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. In our study, the frequency of RRT dependence at 28 days was 40% and 42.85% in the CRRT and SLED cohorts, respectively. Similarly, Kitchlu et al. reported that RRT dependence at 30 days was 32.8% and 38.2% in the CRRT and SLED groups, respectively [<a href="#REF15" class="usa-link" aria-describedby="REF15">15</a>]. Ponce et al. reported that 22.5% of patients presented with renal function recovery, and 5.6% of patients remained on dialysis after 30 days [<a href="#REF21" class="usa-link" aria-describedby="REF21">21</a>].</p>
<p>Recovery of kidney function appears to be the same with CRRT and IHD. Although some studies report better recovery with CRRT, these reports only evaluated renal recovery in patients who survived, thereby failing to account for mortality differences between groups. When the analysis combined mortality and non-recovery of renal function, both groups showed similar recovery of function. These observations were confirmed in a meta-analysis by Scheinder et al. that included 3971 survivors of RRT-requiring AKI. A pooled analysis of 16 observational studies (n = 3499) revealed a higher rate of dialysis dependence associated with IHD, but analysis of seven randomised trials showed no difference in the recovery of kidney function between groups [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. To optimise the relevance of statistical parameters in a non-randomised trial, we performed logistic regression analysis for survivors and non-survivors as well as between the two RRT modalities, i.e., CRRT vs SLED (Table <a href="#TAB9" class="usa-link">9</a>). The analysis revealed that lactate level, serum creatinine at baseline, serum bicarbonate at baseline, and APACHE-2 score showed an odds ratio of more than one. Similarly, when we compared the odds of parameters comparing CRRT with SLED, age, sex, lactate level at baseline, serum pH at baseline, serum Potassium, and APACHE-2 score showed values more than one (Table <a href="#TAB10" class="usa-link">10</a>).</p>
<p>Hypotension, abnormalities in serum electrolytes, albumin, calcium, and phosphate, hypothermia, infection and bleeding, sub-therapeutic antibiotic concentration, arrhythmia, membrane bio incompatibility, and complications due to vascular access are well-recognised complications of RRT. We investigated the most common parameters, namely, filter clotting, hypokalaemia, hypophosphatemia, and arrhythmia. Filter clotting was the most frequent complication observed in our study. It was more common in the CRRT group than in the SLED group; it was observed in 46.87% of the patients in the CRRT group and 18.75% of those in the SLED group (Table <a href="#TAB11" class="usa-link">11</a>). Hypokalaemia and hypophosphatemia were observed in 34.37% and 12.5% of the patients in the CRRT group, respectively, while they were observed in 15.63% and 6.25% in the SLED group, respectively. The incidence of arrhythmia was 18.75% and 9.37% between the CRRT and SLED groups, respectively. </p>
<p>This study had several limitations. First, this was a single-centre observational study comprising a relatively small number of patients with possible allocation bias. A randomised control trial with a larger sample size would have been desirable. Second, we did not compare outcome parameters such as length of ICU stay, ventilation duration, and recovery of renal function beyond one month. The strength of the present study lies in the objective assessment of hemodynamic parameters; however, comparison of modalities in terms of efficacy, fluid balance in the interdialytic period and equivalent renal urea clearance, and cost analysis should have been carried out, which was not done in the current study. In addition, a single-centre setup and small sample size weakened the ability to detect a link between mortality and renal function recovery.</p>
<p>Nevertheless, despite these shortcomings, we have attempted to objectively define the hemodynamic tolerability and efficacy of SLED in patients with AKI and septic shock better than the relatively more costly modality, i.e., CRRT.</p></section><section id="sec5"><h2 class="pmc_sec_title">Conclusions</h2>
<p>Titration of MAP alone was not sufficient to define hemodynamic instability in critically ill patients in the ICU. Hence, the current study reemphasised that the vasopressor index and vasopressor dependency are better indices to assess the hemodynamic stability in critically ill patients with AKI requiring RRT. Both SLED and CRRT showed similar hemodynamic tolerability, mortality profile, and short-term renal recovery in patients with AKI requiring RRT in our study. SLED showed a lower incidence of filter clotting, hypokalemia, and hypophosphatemia when compared with CRRT, although without a statistically significant difference. </p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We would like to acknowledge Dr. M M Bahadur for his encouragement; Dr. Ashay Shringare for helping in acquiring data; Dr. Dharmendra Pratap Singh, Professor, School of Research Methodology, Tata Institute of Social Sciences, Mumbai, for analysing the statistical data; and Dr. Gauri Pathare for formatting the manuscript. We would also like to thank the patients and relatives who gave consent to participate in this study and the hospital staff for their tremendous cooperation during the study period.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Disclosures</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Human subjects:</strong> Informed consent for treatment and open access publication was obtained or waived by all participants in this study. 41st Ethics Committee Meeting (05.08.2017), Jaslok Hospital and Research Center, Mumbai issued approval <a href="https://PR.NO" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PR.NO</a>-939.</p>
<p><strong>Animal subjects:</strong> All authors have confirmed that this study did not involve animal subjects or tissue.</p>
<p><strong>Conflicts of interest:</strong> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p>
<p><strong>Payment/services info:</strong> All authors have declared that no financial support was received from any organization for the submitted work.</p>
<p><strong>Financial relationships:</strong> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p>
<p><strong>Other relationships:</strong> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p>
</div></div></section><section id="fn-group2" class="fn-group"><h2 class="pmc_sec_title">Author Contributions</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2">
<p><strong>Concept and design:</strong>  Choudhury Sudhiranjan Dash, Rishit Harbada, Rushi V. Deshpande, Amjad Khan Pathan</p>
<p><strong>Drafting of the manuscript:</strong>  Choudhury Sudhiranjan Dash, Rishit Harbada</p>
<p><strong>Critical review of the manuscript for important intellectual content:</strong>  Choudhury Sudhiranjan Dash, Rishit Harbada, Rushi V. Deshpande, Amjad Khan Pathan</p>
<p><strong>Supervision:</strong>  Choudhury Sudhiranjan Dash</p>
<p><strong>Acquisition, analysis, or interpretation of data:</strong>  Rishit Harbada</p>
</div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="REF1">
<span class="label">1.</span><cite>Consensus development in acute renal failure: the Acute Dialysis Quality Initiative. Kellum JA, Ronco C, Mehta R, Bellomo R. Curr Opin Crit Care. 2005;11:527–532. doi: 10.1097/01.ccx.0000179935.14271.22.</cite> [<a href="https://doi.org/10.1097/01.ccx.0000179935.14271.22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16292054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Crit%20Care&amp;title=Consensus%20development%20in%20acute%20renal%20failure:%20the%20Acute%20Dialysis%20Quality%20Initiative&amp;volume=11&amp;publication_year=2005&amp;pages=527-532&amp;pmid=16292054&amp;doi=10.1097/01.ccx.0000179935.14271.22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF2">
<span class="label">2.</span><cite>Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Liaño F, Pascual J. Kidney Int. 1996;50:811–818. doi: 10.1038/ki.1996.380.</cite> [<a href="https://doi.org/10.1038/ki.1996.380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8872955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Epidemiology%20of%20acute%20renal%20failure:%20a%20prospective,%20multicenter,%20community-based%20study.%20Madrid%20Acute%20Renal%20Failure%20Study%20Group&amp;volume=50&amp;publication_year=1996&amp;pages=811-818&amp;pmid=8872955&amp;doi=10.1038/ki.1996.380&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF3">
<span class="label">3.</span><cite>Acute renal failure in critically ill patients: a multinational, multicenter study. Uchino S, Kellum JA, Bellomo R, et al.  JAMA. 2005;294:813–818. doi: 10.1001/jama.294.7.813.</cite> [<a href="https://doi.org/10.1001/jama.294.7.813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16106006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Acute%20renal%20failure%20in%20critically%20ill%20patients:%20a%20multinational,%20multicenter%20study&amp;volume=294&amp;publication_year=2005&amp;pages=813-818&amp;pmid=16106006&amp;doi=10.1001/jama.294.7.813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF4">
<span class="label">4.</span><cite>Continuous renal replacement therapies: an update. Manns M, Sigler MH, Teehan BP. Am J Kidney Dis. 1998;32:185–207. doi: 10.1053/ajkd.1998.v32.pm9708602.</cite> [<a href="https://doi.org/10.1053/ajkd.1998.v32.pm9708602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9708602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Continuous%20renal%20replacement%20therapies:%20an%20update&amp;volume=32&amp;publication_year=1998&amp;pages=185-207&amp;pmid=9708602&amp;doi=10.1053/ajkd.1998.v32.pm9708602&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF5">
<span class="label">5.</span><cite>Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Crit Care. 2007;11:0. doi: 10.1186/cc5713.</cite> [<a href="https://doi.org/10.1186/cc5713" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2206446/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17331245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Acute%20Kidney%20Injury%20Network:%20report%20of%20an%20initiative%20to%20improve%20outcomes%20in%20acute%20kidney%20injury&amp;volume=11&amp;publication_year=2007&amp;pages=0&amp;pmid=17331245&amp;doi=10.1186/cc5713&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF6">
<span class="label">6.</span><cite>Does hemodialysis delay recovery from acute renal failure? Conger J. Semin Dial. 2007;3:146–148.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Semin%20Dial&amp;title=Does%20hemodialysis%20delay%20recovery%20from%20acute%20renal%20failure?&amp;volume=3&amp;publication_year=2007&amp;pages=146-148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF7">
<span class="label">7.</span><cite>Extended daily dialysis in acute renal failure: a new therapeutic approach. Kumar N, Ahlawat RS. <a href="https://www.sid.ir/en/vewssid/j_pdf/116620070204.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sid.ir/en/vewssid/j_pdf/116620070204.pdf</a>. Iran J Kidney Dis. 2007;1:63–72.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/19363279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Iran%20J%20Kidney%20Dis&amp;title=Extended%20daily%20dialysis%20in%20acute%20renal%20failure:%20a%20new%20therapeutic%20approach&amp;volume=1&amp;publication_year=2007&amp;pages=63-72&amp;pmid=19363279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF8">
<span class="label">8.</span><cite>Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study. Cornelis T, van der Sande FM, Eloot S, et al.  Am J Kidney Dis. 2014;64:247–256. doi: 10.1053/j.ajkd.2014.02.016.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2014.02.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24698199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Acute%20hemodynamic%20response%20and%20uremic%20toxin%20removal%20in%20conventional%20and%20extended%20hemodialysis%20and%20hemodiafiltration:%20a%20randomized%20crossover%20study&amp;volume=64&amp;publication_year=2014&amp;pages=247-256&amp;pmid=24698199&amp;doi=10.1053/j.ajkd.2014.02.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF9">
<span class="label">9.</span><cite>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Ann Intern Med. 2007;147:573–577. doi: 10.7326/0003-4819-147-8-200710160-00010.</cite> [<a href="https://doi.org/10.7326/0003-4819-147-8-200710160-00010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17938396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Intern%20Med&amp;title=The%20Strengthening%20the%20Reporting%20of%20Observational%20Studies%20in%20Epidemiology%20(STROBE)%20statement:%20guidelines%20for%20reporting%20observational%20studies&amp;volume=147&amp;publication_year=2007&amp;pages=573-577&amp;pmid=17938396&amp;doi=10.7326/0003-4819-147-8-200710160-00010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF10">
<span class="label">10.</span><cite>Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. Wan X, Wang W, Liu J, Tong T. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.</cite> [<a href="https://doi.org/10.1186/1471-2288-14-135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4383202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25524443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med%20Res%20Methodol&amp;title=Estimating%20the%20sample%20mean%20and%20standard%20deviation%20from%20the%20sample%20size,%20median,%20range%20and/or%20interquartile%20range&amp;volume=14&amp;publication_year=2014&amp;pages=135&amp;pmid=25524443&amp;doi=10.1186/1471-2288-14-135&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF11">
<span class="label">11.</span><cite>The Surviving Sepsis Campaign Bundle: 2018 update. Levy MM, Evans LE, Rhodes A. Intensive Care Med. 2018;44:925–928. doi: 10.1007/s00134-018-5085-0.</cite> [<a href="https://doi.org/10.1007/s00134-018-5085-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29675566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Intensive%20Care%20Med&amp;title=The%20Surviving%20Sepsis%20Campaign%20Bundle:%202018%20update&amp;volume=44&amp;publication_year=2018&amp;pages=925-928&amp;pmid=29675566&amp;doi=10.1007/s00134-018-5085-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF12">
<span class="label">12.</span><cite>A pilot randomized controlled trial of comparison between extended daily hemodialysis and continuous veno-venous hemodialysis in patients of acute kidney injury with septic shock. Mishra SB, Azim A, Prasad N, Singh RK, Poddar B, Gurjar M, Baronia AK. Indian J Crit Care Med. 2017;21:262–267. doi: 10.4103/ijccm.IJCCM_85_17.</cite> [<a href="https://doi.org/10.4103/ijccm.IJCCM_85_17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5455018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28584428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20J%20Crit%20Care%20Med&amp;title=A%20pilot%20randomized%20controlled%20trial%20of%20comparison%20between%20extended%20daily%20hemodialysis%20and%20continuous%20veno-venous%20hemodialysis%20in%20patients%20of%20acute%20kidney%20injury%20with%20septic%20shock&amp;volume=21&amp;publication_year=2017&amp;pages=262-267&amp;pmid=28584428&amp;doi=10.4103/ijccm.IJCCM_85_17&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF13">
<span class="label">13.</span><cite>Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. Cruz DN, Antonelli M, Fumagalli R, et al.  JAMA. 2009;301:2445–2452. doi: 10.1001/jama.2009.856.</cite> [<a href="https://doi.org/10.1001/jama.2009.856" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19531784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Early%20use%20of%20polymyxin%20B%20hemoperfusion%20in%20abdominal%20septic%20shock:%20the%20EUPHAS%20randomized%20controlled%20trial&amp;volume=301&amp;publication_year=2009&amp;pages=2445-2452&amp;pmid=19531784&amp;doi=10.1001/jama.2009.856&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF14">
<span class="label">14.</span><cite>The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Zuppa AF, Nadkarni V, Davis L, et al.  Crit Care Med. 2004;32:2318–2322. doi: 10.1097/01.ccm.0000146133.52982.17.</cite> [<a href="https://doi.org/10.1097/01.ccm.0000146133.52982.17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15640648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care%20Med&amp;title=The%20effect%20of%20a%20thyroid%20hormone%20infusion%20on%20vasopressor%20support%20in%20critically%20ill%20children%20with%20cessation%20of%20neurologic%20function&amp;volume=32&amp;publication_year=2004&amp;pages=2318-2322&amp;pmid=15640648&amp;doi=10.1097/01.ccm.0000146133.52982.17&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF15">
<span class="label">15.</span><cite>Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study. Kitchlu A, Adhikari N, Burns KE, et al.  BMC Nephrol. 2015;16:127. doi: 10.1186/s12882-015-0123-4.</cite> [<a href="https://doi.org/10.1186/s12882-015-0123-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4522955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26238520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Nephrol&amp;title=Outcomes%20of%20sustained%20low%20efficiency%20dialysis%20versus%20continuous%20renal%20replacement%20therapy%20in%20critically%20ill%20adults%20with%20acute%20kidney%20injury:%20a%20cohort%20study&amp;volume=16&amp;publication_year=2015&amp;pages=127&amp;pmid=26238520&amp;doi=10.1186/s12882-015-0123-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF16">
<span class="label">16.</span><cite>Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study. Sun Z, Ye H, Shen X, Chao H, Wu X, Yang J. Crit Care. 2014;18:0. doi: 10.1186/cc13827.</cite> [<a href="https://doi.org/10.1186/cc13827" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4056629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24716613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Continuous%20venovenous%20hemofiltration%20versus%20extended%20daily%20hemofiltration%20in%20patients%20with%20septic%20acute%20kidney%20injury:%20a%20retrospective%20cohort%20study&amp;volume=18&amp;publication_year=2014&amp;pages=0&amp;pmid=24716613&amp;doi=10.1186/cc13827&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF17">
<span class="label">17.</span><cite>A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM. Kidney Int. 2001;60:1154–1163. doi: 10.1046/j.1523-1755.2001.0600031154.x.</cite> [<a href="https://doi.org/10.1046/j.1523-1755.2001.0600031154.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11532112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=A%20randomized%20clinical%20trial%20of%20continuous%20versus%20intermittent%20dialysis%20for%20acute%20renal%20failure&amp;volume=60&amp;publication_year=2001&amp;pages=1154-1163&amp;pmid=11532112&amp;doi=10.1046/j.1523-1755.2001.0600031154.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF18">
<span class="label">18.</span><cite>Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Ricci Z, Ronco C, D'Amico G, et al.  Nephrol Dial Transplant. 2006;21:690–696. doi: 10.1093/ndt/gfi296.</cite> [<a href="https://doi.org/10.1093/ndt/gfi296" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16326743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Practice%20patterns%20in%20the%20management%20of%20acute%20renal%20failure%20in%20the%20critically%20ill%20patient:%20an%20international%20survey&amp;volume=21&amp;publication_year=2006&amp;pages=690-696&amp;pmid=16326743&amp;doi=10.1093/ndt/gfi296&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF19">
<span class="label">19.</span><cite>Non-specialist management of acute renal failure. Stevens PE, Tamimi NA, Al-Hasani MK, et al.  QJM. 2001;94:533–540. doi: 10.1093/qjmed/94.10.533.</cite> [<a href="https://doi.org/10.1093/qjmed/94.10.533" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11588212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=QJM&amp;title=Non-specialist%20management%20of%20acute%20renal%20failure&amp;volume=94&amp;publication_year=2001&amp;pages=533-540&amp;pmid=11588212&amp;doi=10.1093/qjmed/94.10.533&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF20">
<span class="label">20.</span><cite>Incidence and outcomes in acute kidney injury: a comprehensive population-based study. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A. J Am Soc Nephrol. 2007;18:1292–1298. doi: 10.1681/ASN.2006070756.</cite> [<a href="https://doi.org/10.1681/ASN.2006070756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17314324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Soc%20Nephrol&amp;title=Incidence%20and%20outcomes%20in%20acute%20kidney%20injury:%20a%20comprehensive%20population-based%20study&amp;volume=18&amp;publication_year=2007&amp;pages=1292-1298&amp;pmid=17314324&amp;doi=10.1681/ASN.2006070756&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF21">
<span class="label">21.</span><cite>Extended daily dialysis in acute kidney injury patients: metabolic and fluid control and risk factors for death. Ponce D, Abrão JM, Albino BB, Balbi AL. PLoS One. 2013;8:0. doi: 10.1371/journal.pone.0081697.</cite> [<a href="https://doi.org/10.1371/journal.pone.0081697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3859511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24349114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Extended%20daily%20dialysis%20in%20acute%20kidney%20injury%20patients:%20metabolic%20and%20fluid%20control%20and%20risk%20factors%20for%20death&amp;volume=8&amp;publication_year=2013&amp;pages=0&amp;pmid=24349114&amp;doi=10.1371/journal.pone.0081697&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF22">
<span class="label">22.</span><cite>High versus low blood-pressure target in patients with septic shock. Asfar P, Meziani F, Hamel JF, et al.  N Engl J Med. 2014;370:1583–1593. doi: 10.1056/NEJMoa1312173.</cite> [<a href="https://doi.org/10.1056/NEJMoa1312173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24635770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=High%20versus%20low%20blood-pressure%20target%20in%20patients%20with%20septic%20shock&amp;volume=370&amp;publication_year=2014&amp;pages=1583-1593&amp;pmid=24635770&amp;doi=10.1056/NEJMoa1312173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF23">
<span class="label">23.</span><cite>Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D. Am J Kidney Dis. 2004;43:342–349. doi: 10.1053/j.ajkd.2003.10.021.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2003.10.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14750100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Efficacy%20and%20cardiovascular%20tolerability%20of%20extended%20dialysis%20in%20critically%20ill%20patients:%20a%20randomized%20controlled%20study&amp;volume=43&amp;publication_year=2004&amp;pages=342-349&amp;pmid=14750100&amp;doi=10.1053/j.ajkd.2003.10.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF24">
<span class="label">24.</span><cite>A pilot randomized controlled comparison of extended daily dialysis with filtration and continuous veno-venous hemofiltration: fluid removal and hemodynamics. Baldwin I, Bellomo R, Naka T, Koch B, Fealy N. Int J Artif Organs. 2007;30:1083–1089. doi: 10.1177/039139880703001208.</cite> [<a href="https://doi.org/10.1177/039139880703001208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18203070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Artif%20Organs&amp;title=A%20pilot%20randomized%20controlled%20comparison%20of%20extended%20daily%20dialysis%20with%20filtration%20and%20continuous%20veno-venous%20hemofiltration:%20fluid%20removal%20and%20hemodynamics&amp;volume=30&amp;publication_year=2007&amp;pages=1083-1089&amp;pmid=18203070&amp;doi=10.1177/039139880703001208&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF25">
<span class="label">25.</span><cite>Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Rabindranath K, Adams J, Macleod AM, Muirhead N. Cochrane Database Syst Rev. 2007:0. doi: 10.1002/14651858.CD003773.pub3.</cite> [<a href="https://doi.org/10.1002/14651858.CD003773.pub3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17636735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20Syst%20Rev&amp;title=Intermittent%20versus%20continuous%20renal%20replacement%20therapy%20for%20acute%20renal%20failure%20in%20adults&amp;publication_year=2007&amp;pages=0&amp;pmid=17636735&amp;doi=10.1002/14651858.CD003773.pub3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF26">
<span class="label">26.</span><cite>Effects of continuous and intermittent renal replacement therapies among adult patients with acute kidney injury. Schoenfelder T, Chen X, Bleß HH. GMS Health Technol Assess. 2017;13:0. doi: 10.3205/hta000127.</cite> [<a href="https://doi.org/10.3205/hta000127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5332811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28326146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=GMS%20Health%20Technol%20Assess&amp;title=Effects%20of%20continuous%20and%20intermittent%20renal%20replacement%20therapies%20among%20adult%20patients%20with%20acute%20kidney%20injury&amp;volume=13&amp;publication_year=2017&amp;pages=0&amp;pmid=28326146&amp;doi=10.3205/hta000127&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF27">
<span class="label">27.</span><cite>Comparing continuous venovenous hemodiafiltration and peritoneal dialysis in critically ill patients with acute kidney injury: a pilot study. George J, Varma S, Kumar S, Thomas J, Gopi S, Pisharody R. Perit Dial Int. 2011;31:422–429. doi: 10.3747/pdi.2009.00231.</cite> [<a href="https://doi.org/10.3747/pdi.2009.00231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21357934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Perit%20Dial%20Int&amp;title=Comparing%20continuous%20venovenous%20hemodiafiltration%20and%20peritoneal%20dialysis%20in%20critically%20ill%20patients%20with%20acute%20kidney%20injury:%20a%20pilot%20study&amp;volume=31&amp;publication_year=2011&amp;pages=422-429&amp;pmid=21357934&amp;doi=10.3747/pdi.2009.00231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF28">
<span class="label">28.</span><cite>Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Schwenger V, Weigand MA, Hoffmann O, et al.  Crit Care. 2012;16:0. doi: 10.1186/cc11445.</cite> [<a href="https://doi.org/10.1186/cc11445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3580725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22839577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Sustained%20low%20efficiency%20dialysis%20using%20a%20single-pass%20batch%20system%20in%20acute%20kidney%20injury%20-%20a%20randomized%20interventional%20trial:%20the%20REnal%20Replacement%20Therapy%20Study%20in%20Intensive%20Care%20Unit%20PatiEnts&amp;volume=16&amp;publication_year=2012&amp;pages=0&amp;pmid=22839577&amp;doi=10.1186/cc11445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF29">
<span class="label">29.</span><cite>Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Zhang L, Yang J, Eastwood GM, Zhu G, Tanaka A, Bellomo R. Am J Kidney Dis. 2015;66:322–330. doi: 10.1053/j.ajkd.2015.02.328.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2015.02.328" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25843704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Extended%20daily%20dialysis%20versus%20continuous%20renal%20replacement%20therapy%20for%20acute%20kidney%20injury:%20a%20meta-analysis&amp;volume=66&amp;publication_year=2015&amp;pages=322-330&amp;pmid=25843704&amp;doi=10.1053/j.ajkd.2015.02.328&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF30">
<span class="label">30.</span><cite>Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Schneider AG, Bellomo R, Bagshaw SM, et al.  Intensive Care Med. 2013;39:987–997. doi: 10.1007/s00134-013-2864-5.</cite> [<a href="https://doi.org/10.1007/s00134-013-2864-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23443311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Intensive%20Care%20Med&amp;title=Choice%20of%20renal%20replacement%20therapy%20modality%20and%20dialysis%20dependence%20after%20acute%20kidney%20injury:%20a%20systematic%20review%20and%20meta-analysis&amp;volume=39&amp;publication_year=2013&amp;pages=987-997&amp;pmid=23443311&amp;doi=10.1007/s00134-013-2864-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cureus are provided here courtesy of <strong>Cureus Inc.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.7759/cureus.88678"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/cureus-0017-00000088678.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (229.1 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374745/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374745/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374745%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374745/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374745/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374745/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374745/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374745/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374745/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="TJCZec2q8IiOnfoP0TJiTl6LXF42f87QJZmVlsB5JWskIrzlVdsjzcsOopwWqK5Z">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
